Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4081/oncol.2021.510 http://scihub22266oqcxt.onion/10.4081/oncol.2021.510 33747366!7967496!33747366     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Oncol+Rev 2021 ; 15 (1): 510 Nephropedia Template TP {{tp|p=33747366|t=2021. Management of COVID-19 in cancer patients receiving cardiotoxic anti-cancer therapy Future recommendations for cardio-oncology |pdf=|usr=}}{{33747366}} gab.com Text Management of COVID-19 in cancer patients receiving cardiotoxic anti-cancer therapy Future recommendations for cardio-oncology JO: Oncol Rev http://www.kidney.de/pget.php?&tw=1&pmid=33747366 #FOAvip Cardiotoxicity induced by anti-cancer treatment has become a significant threat as the number of cardiotoxic anti-cancer agents is growing. Cancer patients are at an increased risk of contracting coronavirus disease 2019 (COVID-19) because of immune suppression caused by anti-cancer drugs and/or supportive treatment. Deterioration in lung functions due to COVID-19 is responsible for many cardiac events. The presence of COVID-19 and some of its treatment modalities may increase the chance of cardiotoxicity development in cancer patients receiving potentially cardiotoxic agents. This review provides evidence-based information on the cardiotoxicity risk in cancer patients clinically diagnosed with COVID-19 who are receiving potentially cardiotoxic anti-cancer agents. Proposed strategies relating to the management of this patient cohorts are also discussed. Twit Text FOAVip Management of COVID-19 in cancer patients receiving cardiotoxic anti-cancer therapy Future recommendations for cardio-oncology ????Oncol Rev http://www.kidney.de/pget.php?&tw=1&pmid=33747366 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33747366 #FOAvip English Wikipedia <ref>{{Cite pmid|33747366}}</ref> Management of COVID-19 in cancer patients receiving cardiotoxic anti-cancer therapy Future recommendations for cardio-oncology #MMPMID33747366 Kobat H; Elkonaissi I; Dorak MT; Nabhani-Gebara S Oncol Rev 2021[Feb]; 15 (1): 510 PMID33747366show ga Cardiotoxicity induced by anti-cancer treatment has become a significant threat as the number of cardiotoxic anti-cancer agents is growing. Cancer patients are at an increased risk of contracting coronavirus disease 2019 (COVID-19) because of immune suppression caused by anti-cancer drugs and/or supportive treatment. Deterioration in lung functions due to COVID-19 is responsible for many cardiac events. The presence of COVID-19 and some of its treatment modalities may increase the chance of cardiotoxicity development in cancer patients receiving potentially cardiotoxic agents. This review provides evidence-based information on the cardiotoxicity risk in cancer patients clinically diagnosed with COVID-19 who are receiving potentially cardiotoxic anti-cancer agents. Proposed strategies relating to the management of this patient cohorts are also discussed. äManagement of COVID-19 in cancer patients receiving cardiotoxic anti-c(epmc).pdf DeepDyve Pubget Overpricing